TELA Bio

TELA

Market cap $32.7M

TELA Hedge Fund Activity: Q1 2026 in Review

36 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in TELA Bio (TELA) for Q1 2026, worth a combined $16.7M — down 49% from $32.5M a quarter earlier.

Sellers outnumbered buyers: 9 funds closed out of TELA and 4 opened new positions — a net loss of 5 holders — while 4 trimmed existing stakes and 14 added.

The largest buyer was Stonepine Capital Management, adding an estimated $230K. The largest seller was UBS Group, cutting an estimated $383K.

• 36 institutional investors held TELA Bio (TELA) as of Q1 2026, down from 42 in Q4 2025.
• Funds reported $16.7M of TELA Bio stock for Q1 2026, down 49% quarter-over-quarter.
• 4 funds opened new TELA Bio positions in Q1 2026 and 9 closed out, a net change of -5 holders.
• The largest TELA Bio buyer in Q1 2026 was Stonepine Capital Management, an estimated $230K added.
• The largest TELA Bio seller in Q1 2026 was UBS Group, an estimated $383K sold.

Based on aggregated 13F filings for Q1 2026.